The primary concern relates not to direct drug interactions between most injectable GLP-1 agonists and levothyroxine, but rather to the potential impact on thyroid monitoring and the theoretical risk associated with thyroid C-cell tumours observed in animal studies
The label itself makes an important admission: it hasnt been established that appetite suppression is its only effect in obesity, because it also produces other central nervous system actions
Studies have also examined GHK-Cu in the context of wound related research and oxidative stress pathways
And overwhelmingly these drugs have only been available for people who have wealth. Kennedy had previously expressed skepticism to GLP-1s in fighting obesity and diseases related to the condition
Hair loss had been reported in weight-management trials and post-marketing data, but important questions remained unanswered: Is the medication itself responsible
The study was a double-blind, placebo-controlled trial with participants receiving once-weekly subcutaneous doses of tirzepatide or a placebo
